Posts Tagged ‘NEST’
Neosync ranked #30 Holder of Pervasive Neurotech Intellectual Property*
Neosync is an early stage company developing a new treatment for major depression based on Transcranial Magnetic Stimulation (TMS). The treatment–named NEST (Neosync EEG Synchronized TMS) and undergoing clinical trials–is based on the idea that depression patients tend to have overly rhythmic brain activity,
Read More